Comparison of ceftazidime, cefuroxime and methicillin in the treatment of Staphylococcus aureus endocarditis in rabbits
Authors:
- 1 October 1984
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 14 (4) , 373-377
Abstract
Ceftazidime, cefuroxime and methicillin proved equally effective in the therapy of experimental Staphylococcus aureus endocarditis in rabbits with a dosing regimen of 40 mg/kg intramuscularly at 8-hourly intervals for three days. Treated animals all demonstrated a thousand to 10,000-fold reduction in the levels of bacteria in the vegetations compared with untreated controls. In-vitro sensitivities of the organism to the test antibiotics were not predictive of therapeutic efficacy in vivo.Keywords
This publication has 7 references indexed in Scilit:
- Cefemandole-aminoglycoside therapy of experimental enterococcal endocarditisJournal of Antimicrobial Chemotherapy, 1983
- Cefoperazone treatment of experimental endocarditisAntimicrobial Agents and Chemotherapy, 1981
- Comparison of ceforanide, cefazolin, methicillin, and nafcillin in Staphylococcus aureus endocarditis therapy in rabbitsAntimicrobial Agents and Chemotherapy, 1980
- INFECTIVE ENDOCARDITIS, 1970-1979 - A STUDY OF CULTURE-POSITIVE CASES IN ST THOMAS HOSPITAL1980
- Effectiveness of Nafcillin, Methicillin, and Cephalothin in Experimental Staphylococcus aureus EndocarditisAntimicrobial Agents and Chemotherapy, 1979
- Nafcillin Therapy for Staphylococcus aureus EndocarditisAntimicrobial Agents and Chemotherapy, 1978
- Treatment of Experimental Staphylococcus aureus Endocarditis: Comparison of Cephalothin, Cefazolin, and MethicillinAntimicrobial Agents and Chemotherapy, 1978